Anti-diabetic activity and pharmacological actions of a new series of sulphonylurea derivatives.
D000284:Administration, Oral; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D003964:Diaphragm / Q000378:metabolism; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005943:Gluconeogenesis / Q000187:drug effects; D005951:Glucose Tolerance Test; D006943:Hyperglycemia / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity; D007275:Injections, Intravenous; D010902:Pituitary Gland; D051381:Rats; D014020:Tissue Extracts
D007004:Hypoglycemic Agents; D014020:Tissue Extracts; D004837:Epinephrine